Literature DB >> 26489455

Prognostic Significance of Peripheral Microvascular Endothelial Dysfunction in Heart Failure With Reduced Left Ventricular Ejection Fraction.

Koichiro Fujisue1, Seigo Sugiyama, Yasushi Matsuzawa, Eiichi Akiyama, Koichi Sugamura, Junichi Matsubara, Hirofumi Kurokawa, Hirofumi Maeda, Yoshihiro Hirata, Hiroaki Kusaka, Eiichiro Yamamoto, Satomi Iwashita, Hitoshi Sumida, Kenji Sakamoto, Kenichi Tsujita, Koichi Kaikita, Seiji Hokimoto, Kunihiko Matsui, Hisao Ogawa.   

Abstract

BACKGROUND: Endothelial dysfunction plays a crucial role in heart failure (HF), but the association between peripheral microvascular endothelial function assessed by reactive hyperemia peripheral arterial tonometry (RH-PAT) and prognosis remains unknown in HF with reduced left ventricular (LV) ejection fraction (HFREF). We prospectively investigated the association between peripheral microvascular endothelial function and HF-related near-future cardiovascular outcomes in HFREF patients. METHODS AND 
RESULTS: The 362 HFREF patients (LVEF <50%) were followed for HF-related events (composite of cardiovascular death and HF hospitalization) up to 3 years. A natural logarithmic-scaled RH-PAT index (Ln-RHI) was obtained for each patient. A total of 82 HF-related events were recorded. The lower-RHI group (Ln-RHI ≤0.49, median) experienced a higher rate of HF-related events compared with the higher-RHI group by Kaplan-Meier analysis (30.9% vs. 14.4%, log-rank test: P<0.001). Multivariable Cox hazard analysis identified Ln-RHI as an independent predictor for HF-related events (per 0.1, hazard ratio: 0.84, 95% confidence interval: 0.75-0.95, P=0.005). Adding Ln-RHI to the Meta-analysis Global Group in Chronic HF risk score (MAGGICs) and Seattle Heart Failure Model (SHFM), powerful prognostic predictors of HF, significantly improved the net reclassification index (MAGGICs: 20.11%, P=0.02, SHFM: 24.88%, P<0.001), and increased the C-statistics for prediction of HF-related events (MAGGICs+Ln-RHI: from 0.612 to 0.670, SHFM+Ln-RHI: from 0.662 to 0.695).
CONCLUSIONS: Peripheral microvascular endothelial dysfunction assessed by RH-PAT was associated with future HF-related events in HFREF.

Entities:  

Mesh:

Year:  2015        PMID: 26489455     DOI: 10.1253/circj.CJ-15-0671

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  13 in total

Review 1.  Depression and Anxiety in Heart Failure: A Review.

Authors:  Christopher M Celano; Ana C Villegas; Ariana M Albanese; Hanna K Gaggin; Jeff C Huffman
Journal:  Harv Rev Psychiatry       Date:  2018 Jul/Aug       Impact factor: 3.732

2.  Chronic antioxidant administration restores macrovascular function in patients with heart failure with reduced ejection fraction.

Authors:  Kanokwan Bunsawat; Stephen M Ratchford; Jeremy K Alpenglow; Soung Hun Park; Catherine L Jarrett; Josef Stehlik; Stavros G Drakos; Russell S Richardson; D Walter Wray
Journal:  Exp Physiol       Date:  2020-06-18       Impact factor: 2.969

3.  Peripheral endothelial dysfunction is a novel risk factor for systolic dysfunction and heart failure progression.

Authors:  Riad Taher; Jaskanwal D Sara; Takumi Toya; Barry A Borlaug; Lilach O Lerman; Amir Lerman
Journal:  Int J Cardiol Heart Vasc       Date:  2020-07-23

4.  Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction.

Authors:  Alexander E Berezin; Alexander A Kremzer; Yulia V Martovitskaya; Tatyana A Berezina; Elena A Gromenko
Journal:  EBioMedicine       Date:  2016-01-20       Impact factor: 8.143

5.  Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.

Authors:  Kenneth M Borow; Alex Yaroshinsky; Barry Greenberg; Emerson C Perin
Journal:  Circ Res       Date:  2019-07-18       Impact factor: 17.367

6.  Impaired Peripheral Endothelial Function Assessed by Digital Reactive Hyperemia Peripheral Arterial Tonometry and Risk of In-Stent Restenosis.

Authors:  Naohiro Komura; Kenichi Tsujita; Kenshi Yamanaga; Kenji Sakamoto; Koichi Kaikita; Seiji Hokimoto; Satomi Iwashita; Takashi Miyazaki; Tomonori Akasaka; Yuichiro Arima; Eiichiro Yamamoto; Yasuhiro Izumiya; Megumi Yamamuro; Sunao Kojima; Shinji Tayama; Seigo Sugiyama; Kunihiko Matsui; Sunao Nakamura; Kiyoshi Hibi; Kazuo Kimura; Satoshi Umemura; Hisao Ogawa
Journal:  J Am Heart Assoc       Date:  2016-06-17       Impact factor: 5.501

7.  Prognostic Value of the CHADS2 Score for Adverse Cardiovascular Events in Coronary Artery Disease Patients Without Atrial Fibrillation-A Multi-Center Observational Cohort Study.

Authors:  Noriaki Tabata; Eiichiro Yamamoto; Seiji Hokimoto; Takayoshi Yamashita; Daisuke Sueta; Seiji Takashio; Yuichiro Arima; Yasuhiro Izumiya; Sunao Kojima; Koichi Kaikita; Kunihiko Matsui; Kazuteru Fujimoto; Kenji Sakamoto; Hideki Shimomura; Ryusuke Tsunoda; Toyoki Hirose; Natsuki Nakamura; Naritsugu Sakaino; Shinichi Nakamura; Nobuyasu Yamamoto; Toshiyuki Matsumura; Ichiro Kajiwara; Shunichi Koide; Tomohiro Sakamoto; Koichi Nakao; Shuichi Oshima; Kenichi Tsujita
Journal:  J Am Heart Assoc       Date:  2017-08-16       Impact factor: 5.501

8.  Endothelial dysfunction and the risk of heart failure in a community-based study: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Johan Ärnlöv; Yingying Sang; Shoshana H Ballew; Dhananjay Vaidya; Erin D Michos; David R Jacobs; Joao Lima; Michael G Shlipak; Alain G Bertoni; Josef Coresh; Michael Blaha; Wendy S Post; Kunihiro Matsushita
Journal:  ESC Heart Fail       Date:  2020-10-20

9.  Improvement of Vascular Endothelial Function Reflects Nonrecurrence After Catheter Ablation for Atrial Fibrillation.

Authors:  Hisanori Kanazawa; Koichi Kaikita; Miwa Ito; Yusei Kawahara; Tadashi Hoshiyama; Yusuke Kanemaru; Takuya Kiyama; Satomi Iwashita; Noriaki Tabata; Kenshi Yamanaga; Koichiro Fujisue; Daisuke Sueta; Seiji Takashio; Yuichiro Arima; Satoshi Araki; Hiroki Usuku; Taishi Nakamura; Yasuhiro Izumiya; Kenji Sakamoto; Satoru Suzuki; Eiichiro Yamamoto; Hirofumi Soejima; Kenichi Matsushita; Kenichi Tsujita
Journal:  J Am Heart Assoc       Date:  2021-08-21       Impact factor: 5.501

10.  Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Authors:  Xiaoteng Ma; Qiaoyu Shao; Lisha Dong; Yujing Cheng; Sai Lv; Hua Shen; Jing Liang; Zhijian Wang; Yujie Zhou
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.